YARGESA — EDENBRIDGE PHARMS, approved 2021-02-10 (ANDA209821).
1,284 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.